A rare complication of idiopathic membranous nephropathy: Crescentic transformation

Renal Failure

Volumn 30, Issue 5, 2008, Pages 573-575

  Unver, Suat ^a   Haholu, Aptullah ^a   Atasoyu, Enes Murat ^a   Karatas, Mustafa ^a   Akcan, Recep ^a   Evrenkaya, T Rifki ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Crescentic transformation; Membranous nephropathy; Re biopsy

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ATORVASTATIN; COMPLEMENT; CREATININE; CYCLOPHOSPHAMIDE; DIPYRIDAMOLE; ESSENTIAL AMINO ACID; FUROSEMIDE; GRANULOCYTE ANTIBODY; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; TRANDOLAPRIL PLUS VERAPAMIL;

AGED; ALBUMINURIA; ARTICLE; CASE REPORT; COMPLEMENT BLOOD LEVEL; CREATININE URINE LEVEL; DRUG PULSE THERAPY; FEMALE; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY SIZE; MEMBRANOUS GLOMERULONEPHRITIS; NAUSEA; NEPHROTIC SYNDROME; PRIORITY JOURNAL; URINE COLOR; URINE SEDIMENT;

EID: 45749121902     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220802064804     Document Type: Article

References (11)

1. Schieppati A, Mosconi L, Perna A, Mecca G, Bertani T, Garattini S, Remuzzi G. Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med. 1993 Jul 8;329(2):85-89.
2. Jha V, Ganguli A, Saha TK, Kohli HS, Sud K, Gupta KL, Joshi K, Sakhuja V. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. J Am Soc Nephrol. 2007 Jun;18(6):1899-1904.
3. Ponticelli C, Zucchelli P, Passerini P, Cesana B, Locatelli F, Pasquali S, Sasdelli M, Redaelli B, Grassi C, Pozzi C et al. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int. 1995 Nov;48(5):1600-1604.
4. Hogan SL, Muller KE, Jennette JC, Falk RJ. A review of therapeutic studies of idiopathic membranous glomerulopathy. Am J Kidney Dis. 1995 Jun;25(6):862-875.
5. Yu HT. Progression of chronic renal failure. Arch Intern Med. 2003 Jun 23;163(12):1417-1429.
6. Hunsicker LG, Adler S, Caggiula A, England BK, Greene T, Kusek JW, Rogers NL, Teschan PE. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int. 1997 Jun;51(6):1908-1919.
7. Klassen J, Elwood C, Grossberg AL. Evolution of membranous nephropathy into antiglomerular basement membranous glomerulonephritis. N Engl J Med. 1974;290:1340-1344.
8. Kurki P, Helve T, von Bonsdorff M, et al. Transformation of membranous glomerulonephritis into crescentic glomerulonephritis with anti-GBM antibodies. Serial determinations of anti-GBM before the transformation. Nephron. 1984;38:134-137.
9. Koethe JD, Gerig JS, Glickman JL, Sturgill BL, Bolton WK. Progression of membranous nephropathy to acute crescentic rapidly progressive glomerulonephritis and response to pulse methlylprednisolone. Am J Nephrol. 1986;6:224-228.
10. Chang A, Aneziokoro O, Meehan SM, Ouigg RJ. Membranous and crescentic glomerulonephritis in a patient with antinuclear and anti-neutrophil cytoplasmic antibodies. Kidney Int. 2007 Feb;71(4):360-365.
11. Hall AM, Symington EM, Sampson SA, Kwan JT. Crescentic transformation of membranous glomerulopathy: A reversible condition. Nephrol Dial Transplant. 2006 Apr;21(4):1136-1137.